BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 12725242)

  • 1. Effects of detergents on the secondary structures of prion protein peptides as studied by CD spectroscopy.
    Kuroda Y; Maeda Y; Sawa S; Shibata K; Miyamoto K; Nakagawa T
    J Pept Sci; 2003 Apr; 9(4):212-20. PubMed ID: 12725242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X-ray diffraction analysis of scrapie prion: intermediate and folded structures in a peptide containing two putative alpha-helices.
    Inouye H; Kirschner DA
    J Mol Biol; 1997 May; 268(2):375-89. PubMed ID: 9159477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane interactions and conformational preferences of human and avian prion N-terminal tandem repeats: the role of copper(II) ions, pH, and membrane mimicking environments.
    Di Natale G; Pappalardo G; Milardi D; Sciacca MF; Attanasio F; La Mendola D; Rizzarelli E
    J Phys Chem B; 2010 Nov; 114(43):13830-8. PubMed ID: 20936829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational properties of peptide fragments homologous to the 106-114 and 106-126 residues of the human prion protein: a CD and NMR spectroscopic study.
    Di Natale G; Impellizzeri G; Pappalardo G
    Org Biomol Chem; 2005 Feb; 3(3):490-7. PubMed ID: 15678187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The structural transition of the prion protein into its pathogenic conformation is induced by unmasking hydrophobic sites.
    Leffers KW; Schell J; Jansen K; Lucassen R; Kaimann T; Nagel-Steger L; Tatzelt J; Riesner D
    J Mol Biol; 2004 Nov; 344(3):839-53. PubMed ID: 15533449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular model of an alpha-helical prion protein dimer and its monomeric subunits as derived from chemical cross-linking and molecular modeling calculations.
    Kaimann T; Metzger S; Kuhlmann K; Brandt B; Birkmann E; Höltje HD; Riesner D
    J Mol Biol; 2008 Feb; 376(2):582-96. PubMed ID: 18158160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The key-role of tyrosine 155 in the mechanism of prion transconformation as highlighted by a study of sheep mutant peptides.
    Bertho G; Bouvier G; Hoa GH; Girault JP
    Peptides; 2008 Jul; 29(7):1073-84. PubMed ID: 18455265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary structure conversions of Alzheimer's Abeta(1-40) peptide induced by membrane-mimicking detergents.
    Wahlström A; Hugonin L; Perálvarez-Marín A; Jarvet J; Gräslund A
    FEBS J; 2008 Oct; 275(20):5117-28. PubMed ID: 18786140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermal stability and conformational transitions of scrapie amyloid (prion) protein correlate with infectivity.
    Safar J; Roller PP; Gajdusek DC; Gibbs CJ
    Protein Sci; 1993 Dec; 2(12):2206-16. PubMed ID: 7905316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical studies of conformational plasticity in a recombinant prion protein.
    Zhang H; Stockel J; Mehlhorn I; Groth D; Baldwin MA; Prusiner SB; James TL; Cohen FE
    Biochemistry; 1997 Mar; 36(12):3543-53. PubMed ID: 9132005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prion protein selectively binds copper(II) ions.
    Stöckel J; Safar J; Wallace AC; Cohen FE; Prusiner SB
    Biochemistry; 1998 May; 37(20):7185-93. PubMed ID: 9585530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural intermediates in the putative pathway from the cellular prion protein to the pathogenic form.
    Jansen K; Schäfer O; Birkmann E; Post K; Serban H; Prusiner SB; Riesner D
    Biol Chem; 2001 Apr; 382(4):683-91. PubMed ID: 11405232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assemblages of prion fragments: novel model systems for understanding amyloid toxicity.
    Satheeshkumar KS; Murali J; Jayakumar R
    J Struct Biol; 2004 Nov; 148(2):176-93. PubMed ID: 15477098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prion protein: Structural features and related toxic peptides.
    Ronga L; Tizzano B; Palladino P; Ragone R; Urso E; Maffia M; Ruvo M; Benedetti E; Rossi F
    Chem Biol Drug Des; 2006 Sep; 68(3):139-47. PubMed ID: 17062011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of prion protein to lipid membranes and implications for prion conversion.
    Sanghera N; Pinheiro TJ
    J Mol Biol; 2002 Feb; 315(5):1241-56. PubMed ID: 11827491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PrP N-terminal domain triggers PrP(Sc)-like aggregation of Dpl.
    Erlich P; Cesbron JY; Lemaire-Vieille C; Curt A; Andrieu JP; Schoehn G; Jamin M; Gagnon J
    Biochem Biophys Res Commun; 2008 Jan; 365(3):478-83. PubMed ID: 17997980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clustered negative charges on the lipid membrane surface induce beta-sheet formation of prion protein fragment 106-126.
    Miura T; Yoda M; Takaku N; Hirose T; Takeuchi H
    Biochemistry; 2007 Oct; 46(41):11589-97. PubMed ID: 17887730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that the 127-164 region of prion proteins has two equi-energetic conformations with beta or alpha features.
    Derreumaux P
    Biophys J; 2001 Sep; 81(3):1657-65. PubMed ID: 11509378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assembly of natural and recombinant prion protein into fibrils.
    Leffers KW; Wille H; Stöhr J; Junger E; Prusiner SB; Riesner D
    Biol Chem; 2005 Jun; 386(6):569-80. PubMed ID: 16006244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micellar environments induce structuring of the N-terminal tail of the prion protein.
    Renner C; Fiori S; Fiorino F; Landgraf D; Deluca D; Mentler M; Grantner K; Parak FG; Kretzschmar H; Moroder L
    Biopolymers; 2004 Mar; 73(4):421-33. PubMed ID: 14991659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.